India  

'Watershed moment in India's battle against COVID': Politicos react over emergency use approval

DNA Sunday, 3 January 2021 ()
DCGI approved Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use.
0
shares
ShareTweetSavePostSend
 
Video Credit: Oneindia - Published
News video: Covid-19: First vaccine shots likely on January 13th, countdown begins|Oneindia News

Covid-19: First vaccine shots likely on January 13th, countdown begins|Oneindia News 01:00

Indians can expect to get their first COVID-19 vaccine shot on January 13. Union Health Ministry announced on Tuesday that the Centre is all set to roll out coronavirus vaccines within 10 days of granting emergency use approval. The announcement by the ministry comes just days after the DCGI approved...

💡 newsR Knowledge: Other News Mentions

Coronavirus disease 2019 Coronavirus disease 2019 Disease caused by severe acute respiratory syndrome coronavirus 2

Tamil Nadu health minister gets Covaxin shot, says ‘let’s end Covid together’ [Video]

Tamil Nadu health minister gets Covaxin shot, says ‘let’s end Covid together’

Tamil Nadu health minister C Vijayabaskar voluntarily took the vaccine Covaxin at Rajiv Gandhi Government General Hospital in Chennai. Vijayabaskar, who is a doctor and a member of the IMA, had earlier said that he was taking the vaccine to instill confidence in the people about the vaccine. Opposition parties have been raising concerns about the efficacy of Covaxin. ‘I got my covaxin shot! Thanks to the team @gmcrgggh for the seamless experience. Appeal everyone to do it when your turn comes. Let's end #Covid19 together,’ Vijayabaskar tweeted after getting the jab. India launched the world’s biggest vaccination drive on 16th of January, 2021 after two vaccines were given approval by authorities. Watch the full video for all the details.

Credit: HT Digital Content    Duration: 02:14Published

Over 10 lakh administered shots against Covid-19; Karnataka tops the list

Nearly 10.5 lakh beneficiaries have received anti-coronavirus shots under the countrywide Covid-19 vaccination, according to the health ministry.
IndiaTimes

Not in favour of granting extra chance to UPSC aspirants who missed exam due to Covid: Centre to SC

The Centre on Friday told the Supreme Court that it was not in favour of granting one more opportunity to those civil services aspirants who could not appear in..
IndiaTimes

Covaxin led to tolerable safety outcomes & enhanced immune responses, says Lancet

Even as a controversy rages over the safety of India’s first indigenous Covid-19 vaccine Covaxin after it was granted Emergency Use Authorisation (EUA) even as..
IndiaTimes

Drugs Controller General of India

‘Indians are not guinea pigs’: Manish Tewari attacks govt over Covaxin approval [Video]

‘Indians are not guinea pigs’: Manish Tewari attacks govt over Covaxin approval

Congress leader Manish Tewari has lashed out at the government over the approval given to Covaxin for the first phase of trials. The Congress leader raised questions over the efficacy of the indigenously developed Covaxin, which is in the third phase of trials and has been cleared for restricted emergency use by the Drugs Controller General of India. ‘Government should act in a manner whereby there's complete confidence in people. You can't use rollout as phase 3 trial, Indians are not guinea pigs,’ Manish Tewari said. The former minister’s remarks come after government hinted that people will not be allowed to choose from the two vaccines recently approved. The first phase of coronavirus vaccination is all set to begin on 16th January, 2021. Watch the full video for all the details.

Credit: HT Digital Content    Duration: 01:40Published
Explained: India announces Covid vaccination launch date; who's first in line? [Video]

Explained: India announces Covid vaccination launch date; who's first in line?

The Government of India announced the launch date of its mass immunisation programme against Covid-19. The vaccinations will begin on January 16, 2021. On January 3, India's drug regulator DCGI had cleared 2 vaccines - Covaxin and Covishield - for emergency use. Covaxin, made by Bharat Biotech, will be used under clinical trial conditions, as per the government. Covishield was developed by Oxford university and pharma major AstraZeneca, and is being made in India by Serum Institute of India (SII). Around 30 crore people are being targeted for vaccination in phase 1. These include healthcare staff, frontline workers like police, those aged above 50, and those aged below 50 but with co-morbidities. Watch the full video for more.

Credit: HT Digital Content    Duration: 01:34Published
Covid: What led to DCGI nod of Covishield & Covaxin in India? IMCR DG explains [Video]

Covid: What led to DCGI nod of Covishield & Covaxin in India? IMCR DG explains

ICMR DG Dr. Balram Bhargava explained the DCGI nod to two Covid-19 vaccines in India. Dr. Bhargava spoke on the various studies done over Covishield and Covaxin. Covishield Oxford-AstraZeneca vaccine which is manufactured at Pune’s Serum Institute of India (SII). Covishield was the first vaccine in India to get the DCGI nod. Soon after, DCGI approved Covaxin. Watch the full video for more details.

Credit: HT Digital Content    Duration: 04:32Published

BBV152 BBV152 Vaccine against COVID-19

TN Health Min takes Bharat Biotech's Covaxin shot in Chennai [Video]

TN Health Min takes Bharat Biotech's Covaxin shot in Chennai

The Health and Family Welfare Minister of Tamil Nadu, Dr C Vijayabaskar took Bharat Biotech's Covaxin shot. He took the shot in Chennai on morning of January 22. Dr C Vijayabaskar requested all to get vaccinated and safeguard themselves from COVID-19 pandemic. Billed as the world's largest vaccination programme, covering the entire length and breadth of the country, the drive aims to first inoculate millions of its healthcare and frontline workers and reach an estimated 3 crore people by the end of its first phase. The mega COVID-19 vaccination drive began in India on January 16 (Saturday).

Credit: ANI    Duration: 01:28Published

Bharat Biotech Bharat Biotech Indian biotechnology company and vaccine manufacturer

Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine

An expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine against..
IndiaTimes
Healthcare workers should be given choice in vaccines: Karnataka resident doctors [Video]

Healthcare workers should be given choice in vaccines: Karnataka resident doctors

Karnataka Association of Resident Doctors (KARD) has demanded the government to let people choose which COVID-19 vaccine, between Pune-based Serum Institute of India's Covishield and Hyderabad-based Bharat Biotech's Covaxin, they want to take. "Government of India has approved Covishield and Covaxin vaccines. We have all the reports for Covishield. But, Covaxin is still in phase-III trials, where the trial is being done on healthcare workers. We condemn this...Healthcare workers should be given a choice of vaccine," said Dr Dayanand Sagar. GoI rolled out COVID-19 vaccine jab from January 16.

Credit: ANI    Duration: 01:30Published

Serum Institute of India Serum Institute of India Indian biotechnological company, vaccine manufacturer

Watch: India sends SII's Covishield vaccines to Mauritius, Seychelles, Myanmar [Video]

Watch: India sends SII's Covishield vaccines to Mauritius, Seychelles, Myanmar

India dispatched consignments of SII's Covishield to Myanmar, Seychelles and Mauritius. India is sending Covid-19 vaccines as part of donation program to neighbours and key partners. Bhutan, Maldives, Bangladesh, Nepal were also part of India's initial rollout of vaccines. In addition, India plans to supply vaccine doses to Afghanistan and Sri Lanka. Covishield's commercial supplies to countries having agreements with SII have also begun. Two flights are slated to carry two million doses each to Brazil and Morocco on Friday. India is carrying out vaccine diplomacy under its 'Neighbourhood First' policy. Last week, India launched the world's biggest Covid-19 vaccination drive across the country.

Credit: HT Digital Content    Duration: 02:46Published

India to send SII's COVID-19 vaccine 'Covishield' to Myanmar, Seychelles, Mauritius

The Ministry of External Affairs had announced a vaccine rollout for Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles from Wednesday.
DNA
COVID vaccine ready for dispatch to Myanmar, Seychelles, Mauritius from Mumbai airport [Video]

COVID vaccine ready for dispatch to Myanmar, Seychelles, Mauritius from Mumbai airport

Serum Institute of India's vaccine consignment arrived at Mumbai's Chhatrapati Shivaji Maharaj International Airport on January 22. The consignment containing COVID-19 vaccine will be dispatched to Myanmar, Seychelles and Mauritius.

Credit: ANI    Duration: 01:17Published

You Might Like


Related videos from verified sources

Authorities to bear hospitalisation cost post Covaxin jab: Health Ministry [Video]

Authorities to bear hospitalisation cost post Covaxin jab: Health Ministry

Health and Family Welfare Ministry of India on January 19 said that in case of the Covaxin which has been given emergency use authorization under clinical trial mode (Covaxin), hospitalization cost..

Credit: ANI     Duration: 01:30Published
Nepal: People cheers after approval of Covishield vaccine manufactured in India [Video]

Nepal: People cheers after approval of Covishield vaccine manufactured in India

After Nepal government approved emergency use of Covishield vaccine, people are hoping the pandemic will falter and human lives would be back on track. Nepal's Department of Drug Administration on..

Credit: ANI     Duration: 02:39Published
'Beginning of the end of Covid-19': Harsh Vardhan on India's vaccination drive [Video]

'Beginning of the end of Covid-19': Harsh Vardhan on India's vaccination drive

Union health minister Dr Harsh Vardhan said that the vaccination drive is 'beginning of the end of covid-19'. He reviewed the preparedness ahead of the Covid-19 vaccination drive in India. "World's..

Credit: HT Digital Content     Duration: 03:02Published

Related news from verified sources

Closing Bell: Sensex at record-high of 48,177, Tata Steel jumps 8.2%

Investor sentiment was lifted after the Drug Controller General of India approved Covid vaccines Covishield and Covaxin for emergency use in the count
DNA

'Covishield' ready to roll out in coming weeks: Poonawalla

Serum Institute of India CEO Adar Poonawalla on Sunday said the Oxford-AstraZeneca Covid-19 vaccine 'Covishield' is ready to roll out in the coming weeks....
IndiaTimes

Covid: Both vaccines get final nod, first shots to be of Covishield

The Serum Institute of India’s Covishield is likely to be first shot used in India’s vaccine drive against Covid-19. For Covaxin, the authorisation is in...
IndiaTimes Also reported by •DNA